https://www.onclive.com/onclive-tv/dr-borgen-on-advancements-with-her2-breast-cancer
Dr. Borgen on Advancements With HER2+ Breast Cancer

Patrick Borgen, MD



Patrick Borgen, MD, chair, Department of Surgery, director, Breast Center, Maimonides Medical Center, discusses advancements in the treatment landscape of HER2-positive breast cancer.

The view of HER2-positive breast cancer has changed, explains Borgen. Previously, HER2-positive breast cancer was thought to be the worst result a biopsy could detect, but targeted treatments have since revolutionized outcomes.
 
Printer Printing...